| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Other | 67.3K | $10.51M | - | |
| Other | 56.8K | $8.87M | - | |
| CFO | 42.8K | $6.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Gorman Kevin Charles55 | Director | Sell | 9,613 | $120.38 | $1,157,211.02 | -1.8% | +9.3% | +27.1% | |
| May 5, 2025 | Rastetter William H48 | Director | Sale+OE | 30,000 | $110.20 | $3,305,952.00 | -44.5% | +16.7% | +23.1% | |
| Feb 14, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 2,218 | $116.44 | $258,263.73 | -5.9% | +4.6% | +7.9% | |
| Feb 13, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 5,844 | $116.69 | $681,914.46 | -1.1% | +1.6% | +6.2% | |
| Feb 13, 2025 | Sherwin Stephen A | Director | Sell | 13,831 | $116.69 | $1,613,922.79 | -56.4% | +1.6% | +6.2% | |
| Feb 13, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 2,154 | $116.73 | $251,427.64 | -4.6% | +1.6% | +6.2% | |
| Feb 13, 2025 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 1,551 | $116.78 | $181,129.15 | -7.1% | +1.6% | +6.2% | |
| Feb 13, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 2,558 | $116.85 | $298,908.05 | -1.8% | +1.6% | +6.2% | |
| Feb 13, 2025 | Boyer David W.51 | Chief Corp. Affairs Officer | Sale+OE | 1,785 | $116.74 | $208,387.31 | -33.4% | +1.6% | +6.2% | |
| Feb 13, 2025 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 2,558 | $116.86 | $298,923.22 | -6.7% | +1.6% | +6.2% |